NCT05282576

Brief Summary

The aim of this study was to investigate the effect of neurophysiological facilitation techniques on respiratory and functional levels in intensive care patients. Participants were divided into two groups as experimental (n=20) and control (n=20). Conventional physiotherapy, which includes chest physiotherapy, mobilization exercises and range of motion exercises were applied in control group. Neurophysiological facilitation techniques in addition to the conventional physiotherapy program ere applied in experimental group. The functional status, lower and upper extremity muscle strength, grip strength measurements of the patients and the rates of weaning from mechanical ventilation were evaluated before and after treatment. Vital signs, dyspnea and fatigue perception were assessed each day of treatment. Evaluations were analyzed statistically using Statistical Package for the Social Sciences-22 program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2020

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2020

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

February 26, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

March 16, 2022

Completed
Last Updated

March 16, 2022

Status Verified

March 1, 2022

Enrollment Period

4 months

First QC Date

February 26, 2022

Last Update Submit

March 8, 2022

Conditions

Keywords

Intensive Care UnitCritical IllPhysiotherapyNeurophysiologic Facilitation TechniquesIntensive Care Unit Acquired Weakness

Outcome Measures

Primary Outcomes (3)

  • The Chelsea Critical Care Physical Assessment Tool

    The Chelsea Critical Care Physical Assessment Tool (CPAx) is a test used on male and female patients in the intensive care unit (ICU) to assess physical and respiratory function impairments and morbidity. The CPAx assessment also identifies patients at risk for developing ICU-acquired complications, such as weakness and mobility decline. The CPAx assesses 10 domains including respiratory function, cough, bed mobility, supine to sitting on edge of bed, dynamic sitting, standing balance, sit to stand, transferring bed to chair, stepping, and grip strength.

    through study completion, an average of 5 days

  • Physical Function in Intensive Care Test

    Physical Function in Intensive Care Test(PFIT) is specifically for the patient population in the intensive care unit (ICU) who are critically ill. This test can be used to guide exercise prescription within the ICU as well as measure functional recovery. The PFIT-s is a battery outcome measure involving four components: sit to stand assistance, marching on the spot cadence, shoulder flexor and knee extensor strength. The PFIT include 4 items.

    through study completion, an average of 5 days

  • Premorbid Level of Activity Scales

    Premorbid dyspnea was scored according to the American Thoracic Society (ATS) scale. The activities of daily living were recorded as 0 = working; 1 = independent (fully ambulatory and living without any assistance); 2 = restricted (able to live on their own and leave their homes to perform basic tasks, but severally limited in exercise ability); 3 = housebound (cannot leave their homes unassisted or leave their homes rarely, able to perform self-care but unable to do heavy chores such as house cleaning, cannot live alone, and may be institutionalized; and 4 = bedridden or wheelchair-bound

    through study completion, an average of 5 days

Secondary Outcomes (9)

  • Change in Heart Rate

    During ICU stay

  • Change in Blood Pressure

    During ICU stay

  • Change in Oxygen saturation

    During ICU stay

  • Change in Respiratory Frequency

    During ICU stay

  • Change in Perception of Fatigue

    During ICU stay

  • +4 more secondary outcomes

Study Arms (2)

Experimental Group

ACTIVE COMPARATOR

We applied neurophysiological facilitation techniques in addition to conventional rehabilitation.

Other: NPF Group

Control Group

OTHER

Critical ill patients was applied their conventional physiotherapy

Other: Control Group

Interventions

Participants allocated to the experimental group completed until discharged, neurophysiological facilitation(NPF) techniques in addition to conventional physiotherapy.

Also known as: Neurophysiological facilitation techniques in addition to conventional physiotherapy.
Experimental Group

Critical ill patients was applied their conventional physiotherapy which includes chest physiotherapy and mobilization until discharged

Also known as: Conventional physiotherapy
Control Group

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinically Unstable
  • Participants Over the Age of 18
  • Individuals who volunteered to participate in the study or were allowed by their first-degree relatives if they were unconscious.
  • Patients who are suitable for physiotherapy by the intensive care specialist.

You may not qualify if:

  • Having coagulation disorder (INR \> 1,5 platelet\<50.000 mm3)
  • Having neuromuscular diseases
  • Having psychiatric disease or overly agitated (Richmond Agitation Sedation Scale score ≥ +2)
  • Having acute stroke
  • Having Raised Intracranial Pressure Syndrome symptoms
  • Having cardiac and respiratory instability (Respiratory frequency \> 30 breaths/min,Partial pressure of oxygen(PaO₂)\< 65 mmHg , fraction of inspired oxygen(FiO₂)\>%55, Diastolic blood pressure \< 50 mmHg or \> 200 mmHg , Systolic blood pressure \< 80 mmHg or \> 200 mmHg)
  • Having hemodynamic instability (intropin dose \> 5 mcg/kg/min)
  • Fever
  • Malignity
  • Shock
  • Patients admitted to ICU after cardiac, trauma and surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istinye University

Istanbul, 34010, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Muscular Diseases

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Musculoskeletal DiseasesNeuromuscular DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Mehmet Burak Uyaroğlu, PT,PhD

    Saglik Bilimleri Universitesi

    STUDY DIRECTOR
  • Yasemin Çırak, Ass.Prof

    Istinye University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 26, 2022

First Posted

March 16, 2022

Study Start

October 1, 2019

Primary Completion

February 1, 2020

Study Completion

March 1, 2020

Last Updated

March 16, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations